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Abstract
Background: As a way to train at faster running speeds, add training volume, prevent injury, or rehabilitate after an injury,
lower-body positive pressure treadmills (LBPPT) have become increasingly commonplace among athletes. However, there
are conflicting evidence and a paucity of data describing the physiological and biomechanical responses to LBPPT running
in highly trained or elite caliber runners at the running speeds they habitually train at, which are considerably faster than
those of recreational runners. Furthermore, data is lacking regarding female runners’ responses to LBPPT running. Therefore,
this study was designed to evaluate the physiological and biomechanical responses to LBPPT running in highly trained male
and female distance runners.
Methods: Fifteen highly trained distance runners (seven male; eight female) completed a single running test composed of
4 × 9-min interval series at fixed percentages of body weight ranging from 0 to 30% body weight support (BWS) in 10%
increments on LBPPT. The first interval was always conducted at 0% BWS; thereafter, intervals at 10, 20, and 30% BWS were
conducted in random order. Each interval consisted of three stages of 3 min each, at velocities of 14.5, 16.1, and 17.7 km·h−1
for men and 12.9, 14.5, and 16.1 km·h−1 for women. Expired gases, ventilation, breathing frequency, heart rate (HR), rating of
perceived exertion (RPE), and stride characteristics were measured during each running speed and BWS.
Results: Male and female runners had similar physiological and biomechanical responses to running on LBPPT. Increasing
BWS increased stride length (p < 0.02) and flight duration (p < 0.01) and decreased stride rate (p < 0.01) and contact time
(p < 0.01) in small-large magnitudes. There was a large attenuation of oxygen consumption (VO2) relative to BWS (p < 0.001),
while there were trivial-moderate reductions in respiratory exchange ratio, minute ventilation, and respiratory frequency
(p > 0.05), and small-large effects on HR and RPE (p < 0.01). There were trivial-small differences in VE, respiratory frequency,
HR, and RPE for a given VO2 across various BWS (p > 0.05).
Conclusions: The results indicate the male and female distance runners have similar physiological and biomechanical
responses to LBPPT running. Overall, the biomechanical changes during LBPPT running all contributed to less metabolic
cost and corresponding physiological changes.
Keywords: AlterG, Lower-body positive pressure, Body weight support, Anti-gravity, Running, Stride characteristics,
Physiological characteristics, Metabolic demand, Oxygen demand, Oxygen cost
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Key Points
 Well-trained male and female distance runners have

similar physiological and biomechanical responses
while running with body weight support on a lowerbody positive pressure treadmill.
 When considering the global unweighing effects on
stride parameters during running, its major
influence was the large increase in flight time, which
contrasted the disproportional decrease in contact
time resulting in overall longer stride length and
reduction in stride rate.
 There was a disproportionate decrease in oxygen
consumption relative to body weight support which
led to an attenuation of heart rate and rating of
perceived exertion and, to a lesser degree,
respiratory exchange ratio, minute ventilation, and
respiratory frequency between each level of body
weight support and running speed.

Background
Body weight support and running velocity both affect
the physiological and biomechanical responses of human
running [1]. Previous studies show that when running at
normal body weight, metabolic demand increases with
velocity [2, 3]. The greater metabolic demand of faster
running speeds has been attributed to increases in stride
frequency, increases in mechanical power, and generation of greater ground reaction forces over shorter
periods of ground contact [2, 4, 5]. Coaches and athletes
have used the increased metabolic demand associated
with faster running velocities as a means of enhancing
aerobic capacity and running performance [6, 7]. However,
running at fast velocities cannot be sustained over extended
durations and greatly increases the risk of overuse and
orthopedic injury [8]. Thus, as a way to train at faster

a
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running speeds, to add training volume, or when people
may not be able to run safely at their full body weight after
orthopedic injury and/or surgery, lower-body positive pressure treadmills (LBPPT), such as the AlterG Anti-Gravity
Treadmill® (AlterG, Inc., Menlo Park, CA) (Fig. 1) that supports the user’s body weight, have become increasingly
commonplace among highly trained athletes [9, 10].
Originally, LBPPT were designed to simulate the musculoskeletal and cardiovascular deconditioning experienced
by astronauts during prolonged exposure to microgravity
environment [11]. The commercially available LBPPT now
have a simple interface that allows the user to select a
desired percentage of body weight at which to run. The device then uses small increases in air pressure around the
user’s lower body to create a lifting force near the subject’s
mass center in order to reduce body weight (Fig. 1) [12].
Compared to the other rehabilitation training options that
simulate unloaded running such as harness systems and
underwater immersion [13–15], LBPPT are more comfortable and therefore allow for extended usage time. Additionally, LBPPT have relatively less impedance compared to
other options, thus simulating normal overground running
kinematics and gait patterns [10]. LBPPT also allow for
running velocities that exceed the capabilities of even the
best distance runners in the world [10, 16], therefore
making it an effective training and rehabilitation tool for
highly trained and elite athletes. Furthermore, providing
body weight support (BWS) allows for attenuation of the
biomechanical risks of running so that movements can
safely be repeated and improved, potentially allowing
athletes to increase training volume or return to running
sooner following injury or surgery. However, athletes using
LBPPT may experience a cardiovascular fitness decline
because of the task’s decreased aerobic demands without
modifying the treadmill velocity at which they run [9, 10,
12, 16–24].

b

Fig. 1 a Schematic depictions of the lower-body positive pressure treadmill (AlterG Anti-Gravity Treadmill® P200) used during testing. b AlterG
Anti-Gravity Treadmill® P200. The lower-body positive pressure treadmill uses an enclosed treadmill body weight support system that makes use
of the ability to increase air pressure around the user’s lower body to create a lifting force near the person’s center of mass. The pressurized
chamber contains an aperture surrounding the subject’s waist. Each subject wore a pair of flexible neoprene shorts that included a kayak-style
spray skirt and a zipper attached to the aperture allowing for an airtight seal around the waist. Expired gases were continuously collected and
measured using a metabolic cart, and biomechanical measures were assessed using high-speed video analysis
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Previous research has shown that equivalent maximal
and submaximal oxygen consumption (VO2) can be
achieved while running on LBPPT by increasing the running speed to offset the reduction in oxygen consumption
associated with running with BWS [12, 20, 22, 25]. When
observed VO2 values were compared with predicted values
[9, 23, 24], the coefficient of determination (R2 = 0.69–0.88)
was large to very large, indicating the derived equation in
their samples was a good fit and it is feasible to derive similar equations in highly trained populations [1]. All studies
that showed reduction in VO2 also showed corresponding
reductions in heart rate (HR) [9, 12, 18, 22–24, 26, 27].
McNeil et al. [9] also reported decreased respiratory
exchange ratio (RER). Raffalt et al. [12] reported decreased
minute ventilation (VE) during unweighted submaximal
running, despite unchanged respiratory rate, whereas
Gojanovic et al. [22] reported no change in VE. Both
Ruckstuhl et al. [18, 27] and McNeil et al. [9] reported
decreased rating of perceived exertion (RPE) with
unweighted submaximal running, whereas Sainton et al.
[26] reported no changes in RPE and Gojanovic et al. [22]
reported an increase in RPE during unweighted maximal
running. However, rather than comparing changes in RPE
across unweighted levels, Hoffman and Donaghe [23]
showed that RPE and HR remained the same for a given
VO2 across various body weight settings. Studies have also
found a decrease [22] and no change [12] in blood lactate
concentration during unweighted maximal running.
Results are also conflicting regarding stride characteristics
while running on LBPPT [10, 12, 22, 26, 28, 29]. Several
studies have reported stride rate decreased with unweighting
[10, 12, 26, 29], whereas Gojanovic et al. [22] found stride
rate increased in males and remained unchanged in females
at different absolute velocities. Grabowski and Kram [10]
reported an increase in contact time, whereas Raffalt et al.
[12] and Neal et al. [29] reported decreased contact time,
and Sainton et al. [26] reported no change in contact time.
However, studies are in agreement that stride length and
flight time increase with unweighting [12, 13, 22, 28, 29].
Sometimes, runners may do a portion of their run on LBPPT
and the remainder overground. In studies examining the
effects of reloading at 100% body weight after previous
unweighting, stride rate decreased in one study [26], whereas
it was unchanged in another [10]. Grabowski and Kram [10]
found contact time increased, and Sainton et al. [26] found
flight time increased following unweighted running, which

partially explains the anecdotal heavy-feeling athlete’s experience after prolonged periods on LBPPT.
Unfortunately, while these studies provide valuable
insight into the physiological and biomechanical demands of running on LBPPT among healthy and recreational runners, there are conflicting evidence and a
paucity of data indicating how these results might apply
to highly trained or elite caliber runners at the running
speeds they habitually train at, which are considerably
faster than those of recreational runners [9]. Of the ten
studies that met the inclusion criteria for evaluation of
physiologic and stride characteristic parameters in a recent systematic review [1], only two studies included
highly trained or elite caliber distance runners [9, 12],
neither of which included female runners. Previous research has established that differences in physiological and
biomechanical characteristics exist between highly trained
male and female runners during submaximal normal body
weight running [3, 30]. However, data is limited regarding
female athlete’s physiological and biomechanical responses
to LBPPT running. Lastly, a comprehensive examination of
physiological and biomechanical responses to LBPPT running in the same population is lacking. Therefore, this study
was designed to evaluate the physiological and stride characteristic responses to LBPPT running in highly trained
male and female distance runners.

Methods
Subjects

Fifteen highly trained distance runners (seven male; eight female) participated in this study (Table 1). Not all subjects
met the criteria to be classified as “elite” according to Barnes
and Kilding [2]; therefore, subjects in the present study were
considered “highly trained.” Inclusion criteria were to have 1mile personal best under 4 min and 10 s or 5 min, 5-km personal best under 14 min and 30 s or 17 min, or 10-km
personal best under 30 or 35 min for men and women,
respectively. Eight of the subjects (four male; four female)
were heel strikers, and seven were mid-forefoot strikers. Foot
strike was verified by high-speed video analysis. All subjects
had prior experience running on LBPPT and refrained from
any activities they were unaccustomed to in the 3 days prior
to testing. The study was approved by the Grand Valley State
University Human Research Review Committee (Reference
No. 14–176-H) and performed in accordance with the

Table 1 Subject and training characteristics
N

Age (years)

Body mass (kg)

Height (m)

Training history (years)

Training volume (km·wk−1)

IAAF scorea

Male

7

22.1 ± 0.9

68.4 ± 2.2

1.67 ± 0.07

8.1 ± 1.2

135 ± 21

943 ± 46

Female

8

21.4 ± 2.1

54.3 ± 5.0

1.79 ± 0.03

7.3 ± 2.1

84 ± 19

996 ± 60

Data are mean ± SD
a
International Association of Athletics Federations (IAAF) 2015 scoring tables [37]
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standards of ethics outlined in the Declaration of Helsinki.
All participants provided informed written consent to
participate.
Experimental Testing

The subjects completed a single running test composed
of 4 × 9-min interval series at fixed percentages of body
weight ranging from 0 to 30% BWS in 10% increments
on the AlterG Anti-Gravity P200 Treadmill® (AlterG®,
Inc., Fremont, CA) (Fig. 1) set at a 1.0% gradient [31].
Prior to experimental testing, subjects performed a 5-min
warmup on the LBPPT (0% BWS) at their own selfselected pace, but below that of the first experimental testing velocity. The first interval was always conducted at 0%
BWS; thereafter, intervals at 10, 20, and 30% BWS were
conducted in random order. Each interval consisted of
three stages of 3 min each (9 min total), at velocities of
14.5, 16.1, and 17.7 km·h−1 (4.03, 4.47, and 4.92 m·s−1, respectively) for men and 12.9, 14.5, and 16.1 km·h−1 (3.58,
4.03, and 4.47 m·s−1, respectively) for women, always progressing from the slowest to fastest pace with 10-min recovery between intervals. The treadmill was calibrated
before each testing session. The decision to take measurements with 10 to 30% BWS was based on previous research, indicating the actual amount of support provided
by LBPPT is the most accurate between 10 and 40% BWS
[32], as well as anecdotal observation that 30% BWS tends
to be the maximum amount of support prescribed for athletes during training and rehabilitation. Furthermore, we
took a capillary blood lactate samples (Lactate Pro, Arkray, KDK, Japan) from the fingertip at the conclusion of
each interval and determined blood lactate concentrations
remained below 4 mmol·L−1 (range 1.9 to 3.4 mmol·L−1 at
the fastest running velocity), indicating the paces were
within normal training paces for these athletes.
Throughout the running test, heart rate (Polar RS800sd,
Polar Electro, Kempele, Finland) and expired gases were
continuously collected and measured using a metabolic
cart (ParvoMedics TrueOne 2400, Salt Lake City, UT) to
determine VO2, carbon dioxide production (VCO2), VE,
and RER. RPE was determined during each stage using a
standard Borg RPE scale upon completion of each interval
[33]. Biomechanical measures (stride rate, stride length,
contact time, and flight time) were determined using
high-speed video analysis (240 frames·s−1) while running
at each velocity and BWS [30]. The average physiological
and biomechanical parameters during the final minute of
each running speed and BWS were used for analysis.
Statistical Analyses

Data analyses were performed using SPSS, version 20.0
(SPSS Inc., Chicago, IL), and customized spreadsheets.
Means ± standard deviations were calculated for physiological and biomechanical characteristics using the last
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minute of data collection for each speed and BWS. Comparisons of the differences between genders were made
using a spreadsheet for comparing two groups [34]. The effects of BWS on physiological and biomechanical measures
were analyzed with a spreadsheet for post-only crossovers
[35]. The value at 0% BWS of the dependent variable was
included as a covariate to improve precision of the estimate
of the effects. Effects were estimated in percent units via
log transformation, and uncertainty in the estimate was
expressed as 90% confidence limits. The effect size (ES),
which represents the magnitude of the difference between
the two conditions in terms of SD, was calculated from the
log-transformed data by dividing the change in the mean
by the average SD of the two conditions. Magnitudes of
effects on all measures were evaluated non-clinically: if the
confidence interval overlapped thresholds for small positive
and negative values, the effect was deemed unclear; all
other effects were reported as the magnitude of the
observed value and were evaluated probabilistically as
described above, except that threshold values for trivial,
small, moderate, large, very large, and extremely large
effects were < 0.2, 0.2, 0.6, 1.2, 2.0, and 4.0 of the betweensubject standard deviation in the control condition [36].
Linear regression analysis performed on the mean values
defined the linear relationship (linear equation and Pearson
correlation coefficients) between VO2 and running speed.

Results
Descriptive characteristics of the runners are presented in
Table 1. There were trivial differences between men and
women in age (p = 0.07), training history (p = 0.23), and
personal bests at racing distances between 1 mile and
10 km as represented by IAAF scores [37] (p = 0.82).
However, males were moderately taller (p = 0.005), very
largely heavier (p < 0.001), and trained at a very largeamount higher volume than females (p = 0.001).

Biomechanical Responses

Biomechanical responses of male and female athletes to
BWS across three running velocities are presented in
Tables 2 and 3, respectively. Overall, in both men and
women, stride rate and contact time decreased with increasing BWS, while stride length and flight duration increased with increasing levels of BWS. There were
small-moderate decreases in stride rate (p < 0.01) and
moderate-very large decreases in contact time (p < 0.01)
with increases in BWS for both men and women. Stride
length (p ≤ 0.02) and flight duration (p < 0.01) increased
in small-large magnitudes with increasing BWS in both
males and females. The largest increases or decreases in
biomechanical characteristics tended to occur between
10 and 20% BWS or between 20 and 30% BWS.

185.1 ± 8.7

139.6 ± 12.3

147.9 ± 11.8

167.4 ± 10.6

185.9 ± 10.4

30% BWS

0% BWS

10% BWS

20% BWS

30% BWS

− 1.6 ± 0.6 (0.90)

− 3.8 ± 1.0 (2.14)

11.0 ± 1.5 (1.12)

13.4 ± 1.9 (1.35)

− 6.1 ± 1.8 (1.59)

− 11.6 ± 1.9 (3.12)

− 1.0 ± 0.4 (0.35)
− 3.6 ± 1.0 (2.14)

− 2.0 ± 1.0 (1.24)

− 2.8 ± 0.9 (0.68)
− 11.1 ± 2.2 (2.80)

− 6.1 ± 1.4 (1.51)

189.7 ± 9.7

173.1 ± 10.2

152.4 ± 12.3

144.6 ± 12.0

31.5 ± 3.9 (2.85)

19.9 ± 3.6 (1.89)

5.4 ± 0.8 (0.55)

Flight duration (ms)

175.9 ± 9.1

192.1 ± 7.6
185.6 ± 7.2

− 3.8 ± 1.2 (0.96)

− 2.2 ± 2.0 (0.56)

197.7 ± 7.2

− 5.9 ± 1.1 (1.52)

33.4 ± 3.0 (3.09)

8.5 ± 0.8 (1.63)

Contact time (ms)

174.8 ± 1.9

179.6 ± 2.8

181.4 ± 3.0

177.9 ± 1.7

20.1 ± 2.5 (1.96)

2.7 ± 1.2 (0.53)
4.8 ± 1.1 (0.94)

Stride rate (steps·min−1)

1.80 ± 0.09

1.74 ± 0.06

1.70 ± 0.07

1.66 ± 0.07

− 1.6 ± 0.8 (0.89)

5.9 ± 1.2 (0.62)

Difference between 0%
BWS ± 90 CL (ES)

Stride length (m)

16.1 km·h−1
(4.47 m·s−1)

− 0.6 ± 0.4 (0.35)

2.4 ± 2.1 (0.43)

5.4 ± 0.8 (0.94)

Difference between
BWS ± 90 CL (ES)b

− 2.2 ± 0.9 (1.24)

11.1 ± 2.0 (1.89)

8.5 ± 2.7 (1.46)

2.9 ± 2.3 (0.52)

Difference between 0%
BWS ± 90 CL (ES)a

9.6 ± 1.1 (0.95)

13.7 ± 3.8 (1.34)

− 5.3 ± 1.6 (1.29)

− 3.4 ± 1.8 (0.83)

− 1.7 ± 0.5 (0.90)

− 0.9 ± 0.8 (0.89)

3.5 ± 1.5 (0.69)

2.1 ± 0.9 (0.42)

Difference between
BWS ± 90 CL (ES)

192.7 ± 10.2

175.4 ± 12.3

163.3 ± 10.0

155.7 ± 11.6

167.7 ± 7.9

172.7 ± 7.7

179.0 ± 6.5

184.4 ± 6.8

177.0 ± 2.1

179.7 ± 2.5

181.4 ± 3.2

182.6 ± 2.6

1.87 ± 0.08

1.81 ± 0.07

1.77 ± 0.06

1.75 ± 0.06

17.7 km·h−1
(4.92 m·s−1)

23.9 ± 2.3 (2.49)

12.9 ± 1.3 (1.41)

4.9 ± 3.7 (0.56)

− 9.1 ± 1.2 (2.25)

− 6.4 ± 1.0 (1.55)

− 2.9 ± 0.7 (0.70)

− 3.0 ± 0.8 (1.85)

− 1.6 ± 0.5 (0.94)

− 0.6 ± 0.4 (0.38)

6.4 ± 0.8 (1.48)

3.3 ± 0.4 (0.76)

1.0 ± 0.8 (0.23)

Difference between 0%
BWS ± 90 CL (ES)

Data are means ± SD
BWS body weight support, CL confidence limits, ES effect size
a
Represents the difference as percent ± 90 CL and the effects between levels of BWS and 0% BWS (e.g., 0% BWS and 10% BWS; 0% BWS and 20% BWS; 0% BWS and 30% BWS)
b
Represents the difference as percent ± 90 CL and the effects between 10% BWS and 20% BWS or between 20% BWS and 30% BWS

204.9 ± 8.0

197.1 ± 6.9

10% BWS

209.4 ± 7.2

0% BWS

20% BWS

172.9 ± 1.4

30% BWS

179.7 ± 2.8

0% BWS

178.6 ± 2.8

1.70 ± 0.09

30% BWS

175.7 ± 1.8

1.66 ± 0.06

20% BWS

10% BWS

1.57 ± 0.06

10% BWS

20% BWS

1.53 ± 0.07

0% BWS

14.5 km·h−1 (4.03 m·s−1)

Table 2 Biomechanical characteristics of male runners by velocity and different levels of body weight support

9.8 ± 1.9 (1.08)

7.6 ± 3.6 (0.85)

− 2.9 ± 0.8 (0.69)

− 3.5 ± 1.1 (0.85)

− 1.5 ± 0.5 (0.91)

− 0.9 ± 0.5 (0.56)

3.1 ± 0.7 (0.72)

2.2 ± 0.9 (0.53)

Difference between
BWS ± 90 CL (ES)
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191.5 ± 8.5

127.5 ± 8.2

138.8 ± 6.1

160.5 ± 6.8

181.4 ± 8.5

30% BWS

0% BWS

10% BWS

20% BWS

30% BWS

− 1.8 ± 0.5 (0.89)

− 4.2 ± 0.9 (2.10)

13.0 ± 1.2 (1.96)

15.7 ± 2.9 (1.64)

− 6.1 ± 1.7 (2.18)

− 14.5 ± 1.4 (5.40)

− 4.0 ± 1.1 (1.83)

− 2.6 ± 0.8 (1.20)

− 0.5 ± 0.6 (0.21)

− 2.7 ± 0.9 (0.77)
− 14.4 ± 1.3 (4.42)

− 11.0 ± 0.8 (3.31)

185.5 ± 8.0

169.1 ± 8.8

143.1 ± 7.1

130.6 ± 7.7

42.1 ± 2.7 (5.22)

29.5 ± 1.9 (3.84)

9.6 ± 2.3 (1.36)

Flight duration (ms)

180.5 ± 6.3

205.1 ± 7.2
187.6 ± 6.2

− 5.4 ± 1.4 (1.90)

− 3.8 ± 1.3 (1.32)

210.8 ± 6.6

− 8.9 ± 1.9 (3.22)

42.4 ± 2.9 (4.74)

10.4 ± 1.0 (2.05)

Contact time (ms)

176.5 ± 1.9

182.9 ± 2.8

183.9 ± 3.0

179.0 ± 1.7

26.0 ± 2.9 (3.10)

3.2 ± 1.5 (0.64)
6.2 ± 0.9 (1.24)

Stride rate (steps·min−1)

1.71 ± 0.09

1.65 ± 0.08

1.60 ± 0.09

1.55 ± 0.07

− 2.1 ± 0.5 (1.01)

8.9 ± 4.5 (1.15)

Difference between 0%
BWS ± 90 CL (ES)

Stride length (m)

14.5 km·h−1
(4.47 m·s−1)

− 2.5 ± 0.7 (1.21)

6.5 ± 0.8 (0.93)

2.2 ± 0.3 (0.31)

Difference between
BWS ± 90 CL (ES)b

− 0.4 ± 0.6 (0.20)

22.2 ± 1.7 (2.98)

14.8 ± 1.6 (2.05)

12.4 ± 1.4 (1.74)

Difference between 0%
BWS ± 90 CL (ES)a

9.7 ± 1.3 (1.38)

18.1 ± 3.4 (2.48)

− 3.8 ± 0.6 (1.11)

− 8.5 ± 0.9 (2.54)

− 1.4 ± 0.5 (0.63)

− 2.2 ± 0.7 (0.99)

4.0 ± 0.7 (0.81)

2.9 ± 1.0 (0.59)

Difference between
BWS ± 90 CL (ES)

190.3 ± 9.1

173.1 ± 8.0

152.8 ± 7.9

137.8 ± 7.9

171.1 ± 6.7

177.8 ± 6.3

188.3 ± 7.1

197.1 ± 6.7

178.6 ± 2.3

181.8 ± 2.7

184.5 ± 3.4

186.1 ± 3.9

1.77 ± 0.08

1.73 ± 0.08

1.69 ± 0.08

1.65 ± 0.08

16.1 km·h−1
(4.92 m·s−1)

38.2 ± 1.3 (4.90)

25.7 ± 1.5 (3.47)

10.9 ± 1.0 (1.57)

− 13.2 ± 0.5 (3.74)

− 9.8 ± 0.4 (2.73)

− 4.5 ± 1.1 (1.22)

− 4.0 ± 1.1 (1.72)

− 2.3 ± 0.8 (0.99)

− 0.9 ± 0.5 (0.37)

7.2 ± 0.5 (1.34)

4.6 ± 0.5 (0.87)

2.3 ± 0.4 (0.45)

Difference between 0%
BWS ± 90 CL (ES)

Data are means ± SD
BWS body weight support, CL confidence limits, ES effect size
a
Represents the difference as percent ± 90 CL and the effects between levels of BWS and 0% BWS (e.g., 0% BWS and 10% BWS; 0% BWS and 20% BWS; 0% BWS and 30% BWS)
b
Represents the difference as percent ± 90 CL and the effects between 10% BWS and 20% BWS or between 20% BWS and 30% BWS

215.6 ± 6.1

204.0 ± 6.8

10% BWS

224.0 ± 8.2

0% BWS

20% BWS

174.6 ± 2.4

30% BWS

182.4 ± 3.3

0% BWS

181.6 ± 2.8

1.62 ± 0.08

30% BWS

177.9 ± 2.5

1.52 ± 0.07

20% BWS

10% BWS

1.49 ± 0.07

10% BWS

20% BWS

1.33 ± 0.08

0% BWS

12.9 km·h−1 (4.03 m·s−1)

Table 3 Biomechanical characteristics of female runners by velocity and different levels of body weight support

9.9 ± 1.2 (1.43)

13.4 ± 1.2 (1.90)

− 3.7 ± 0.5 (1.01)

− 5.6 ± 1.3 (1.51)

− 1.7 ± 0.6 (0.73)

− 1.5 ± 0.5 (0.63)

2.5 ± 0.5 (0.47)

2.2 ± 0.5 (0.43)

Difference between
BWS ± 90 CL (ES)
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Physiological Responses

Physiological responses of male and female athletes to
BWS across three running velocities are presented in
Tables 4 and 5, respectively. There were large-extremely
large effects on running economy (VO2) at each speed
and between all BWS for men (p ≤ 0.001) and
moderate-large effects for women (p < 0.001). There
were trivial differences between the first 15 s and the last
15 s of the last minute analyzed at each running speed
and BWS, indicating our subjects did achieve a steady
state during each interval series. Equations from linear
regression analyses defining VO2 (ml·kg−1·min−1) as
functions of running speed (m·s−1) at each BWS are presented in Table 6. There was increased variability with
additional BWS (from 0.993 to 0.973 in men and 0.985
to 0.929 in women); however, coefficients of determinations (R2) were nearly perfect between 0 and 30% BWS
[36]. For both men and women, effects on RER were
trivial-small with only significant differences between 0
and 10% BWS at 16.1 km·h−1 (p = 0.02) for men and 20
and 30% BWS at 16.1 km·h−1 (p = 0.04) for women.
Minute ventilation and respiratory frequency decreased
in trivial-moderate magnitudes with BWS (p > 0.05).
Heart rate decreased with increasing BWS at moderatelarge magnitudes (p < 0.01) in men except between 20
and 30% BWS at 16.1 and 17.7 km·h−1 (p = 0.14 and
0.08, respectively). In females, HR decreased significantly
(p < 0.05) at 14.5 and 16.1 km·h−1 with increasing BWS,
but not 12.9 km·h−1 (p > 0.08). Rating of perceived exertion went down in mostly small-moderate magnitudes
with increasing BWS across all speeds (p < 0.01). There
were trivial-small differences in VE, respiratory frequency, HR, and RPE for a given VO2 across various
BWS (p > 0.05).

Discussion
This is the first study to assess the physiological and
biomechanical responses of running on a LBPPT among
highly trained female distance runners across typical
training speeds and different levels of BWS, while it adds
to the body of literature regarding highly trained male
distance runners. The most important finding of the
current study is that male and female runners had
similar physiological and biomechanical responses to
running on LBPPT. In general, we found that increasing
BWS on a LBPPT increased stride length and flight duration and decreased stride rate and contact time while
attenuating a variety of physiological characteristics at a
range of treadmill velocities.
Biomechanical changes to LBPPT running are not well
defined and, in the case of stride characteristics, are
inconsistent. When considering the global unweighing
effects on stride parameters during running, its major
influence was the large increase in flight time, which
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contrasted the disproportional decrease in contact time
resulting in overall longer stride length and reduction in
stride rate. Sainton et al. [26] described this pattern of
movement as similar to the gait patterns adopted by
astronauts on the Moon as defined by Minetti et al. [38].
Studies are in agreement that unweighing-induced
changes in flight time increase with increasing levels of
BWS [12, 13, 26, 29]. In our study, flight time was less
affected by higher running speeds but was significantly
affected by BWS. Presumably, the BWS provides a longer swing phase and theoretically lowers the working
demand of the hip flexion muscles [12].
Both the current data and those of previous studies
[12, 22, 28, 29] are in disagreement with the work of
Mercer and Chona [39] who reported no effects on
stride length with increased BWS. We found small to
moderate increases in stride length with each 10% incremental increase in BWS. These findings support our observation that flight time increases with BWS, in line
with others’ observations of increased flight times and
stride durations [12, 13, 26, 29]. The effect of BWS on
stride length seems to be less when running at faster
speeds. There was a 22% increase in stride length at
12.9 km·h−1 from 0 to 30% BWS compared to only 7%
increase at 16.1 km·h−1 in females. Raffalt et al. [12] reported similar phenomena in stride rate and stride
length. In this study, flight time was also affected less at
faster running velocities, indicating that the running pattern was less affected by BWS at higher running speeds.
There is a natural reciprocal relationship between stride
length and stride rate [30]; therefore, it is not surprising then
to find reductions in stride rate, considering the increases in
stride length in the present study and others with increasing
BWS [10, 12, 26, 29]. Only Gojanovic et al. [22, 25] have reported increases in stride rate during BWS running, but that
was only in male runners during maximal or supramaximal
running velocities. Mercer and Chona [39] and Gojanovic et
al. [22] reported no change in stride rate with BWS in males
and females during maximal or supramaximal running
speeds. An increase in stride rate has been reported to
reduce the risk of chronic knee injuries by reducing joint
loading and increasing gluteal activation [40]. Conversely, decreasing stride rate may place the knee joint under greater
load and potentially increase the risk of injury [29]. Given
that LBPPT are intended for rehabilitating injured athletes,
preventing injuries, and enhancing performance, it is important that training benefits achieved on LBPPT translate to
overground running too [1]. Our results and others support
that running on a LBPPT at submaximal running speeds
promotes a decrease in stride rate [10, 12, 26, 29], which
may not be beneficial for athletes trying to add training volume, prevent injury, or rehabilitate an injury. However, there
is no evidence suggesting the effects of LBPPT running persist for a long term after returning to overground running.

30.9 ± 1.3

28.1 ± 1.6

0.82 ± 0.04

0.83 ± 0.04

0.83 ± 0.04

0.83 ± 0.04

52.3 ± 5.8

50.1 ± 4.6

48.6 ± 4.1

46.2 ± 2.6

34.4 ± 4.6

34.0 ± 5.1

33.4 ± 3.5

29.4 ± 4.2

143 ± 5

135 ± 6

126 ± 3

121 ± 5

13.7 ± 1.3

11.9 ± 0.7

10.6 ± 0.8

9.9 ± 0.9

10% BWS

20% BWS

30% BWS

0% BWS

10% BWS

20% BWS

30% BWS

0% BWS

10% BWS

20% BWS

30% BWS

0% BWS

10% BWS

20% BWS

30% BWS

0% BWS

10% BWS

20% BWS

30% BWS

0% BWS

10% BWS

20% BWS

30% BWS

− 9.0 ± 4.6 (1.59)

− 38.1 ± 7.8 (8.04)

0.83 ± 0.04

− 1.4 ± 1.4 (0.14)

51.3 ± 6.3

− 3.7 ± 5.4 (0.27)

− 11.3 ± 10.9 (0.86)

− 12.0 ± 8.8 (1.12)

− 9.8 ± 4.3 (0.90)

− 5.7 ± 4.4 (0.51)

−1

32.7 ± 5.7

− 13.0 ± 15.6 (0.78)

− 0.7 ± 10.1 (0.04)

− 12.3 ± 19.0 (0.74)

132 ± 5

− 7.0 ± 1.9 (1.88)
− 3.9 ± 2.2 (1.03)

− 11.7 ± 3.3 (3.21)

− 15.1 ± 4.9 (4.23)

11.4 ± 0.8

− 10.9 ± 4.7 (1.12)
− 6.9 ± 5.0 (0.69)

− 22.8 ± 4.8 (2.51)

− 28.1 ± 7.4 (3.19)

11.0 ± 0.6

12.6 ± 0.8

− 13.4 ± 6.9 (1.39)

14.7 ± 1.1

129 ± 7

143 ± 5

− 5.0 ± 2.6 (1.33)

150 ± 6

31.2 ± 2.7

34.9 ± 5.0
1.3 ± 8.3 (0.07)

2.2 ± 13.0 (0.12)

35.6 ± 4.7

− 25.2 ± 9.3 (3.48)

− 22.3 ± 9.4 (3.03)

− 14.5 ± 4.7 (1.88)

RPE (6–20 AU)

− 14.3 ± 3.5 (3.08)

− 11.9 ± 3.5 (2.52)

− 4.8 ± 2.7 (0.99)

Heart rate (BPM)

− 11.3 ± 14.1 (0.71)

− 7.8 ± 8.9 (0.49)

− 2.2 ± 9.2 (0.13)

Respiratory frequency (breathes·min )

49.9 ± 4.7

53.3 ± 4.6
− 4.3 ± 5.6 (0.32)

− 6.2 ± 5.3 (0.46)

56.8 ± 5.7

− 3.7 ± 4.8 (1.15)

− 9.1 ± 5.6 (0.45)

− 2.8 ± 3.2 (0.56)

− 7.4 ± 2.1 (1.53)

− 4.1 ± 16.2 (0.25)

− 8.3 ± 9.9 (0.52)

− 2.5 ± 9.5 (0.22)

− 5.5 ± 7.7 (0.50)

0.0 ± 1.0 (0.00)

11.7 ± 0.8

12.4 ± 1.0

13.6 ± 0.8

15.6 ± 1.3

137 ± 8

141 ± 5

150 ± 6

157 ± 8

33.6 ± 4.2

33.8 ± 5.0

36.1 ± 4.6

37.0 ± 5.1

54.9 ± 5.0

55.4 ± 4.8

59.5 ± 6.0

60.4 ± 7.8

0.84 ± 0.03

0.84 ± 0.04

− 2.6 ± 2.4 (0.51)

0.85 ± 0.03

0.86 ± 0.04

37.2 ± 2.5

41.3 ± 2.6

49.8 ± 3.4

57.8 ± 2.9

17.7 km·h−1
(4.92 m·s−1)

− 1.9 ± 1.9 (0.38)

− 1.1 ± 2.5 (0.21)

− 8.1 ± 2.7 (1.60)

− 17.4 ± 4.9 (3.61)

Difference between
BWS ± 90 CL (ES)

− 1.2 ± 0.9 (0.24)

Minute ventilation (L·min−1)

0.83 ± 0.04

0.9 ± 1.6 (0.22)

0.83 ± 0.03

0.84 ± 0.03

− 5.2 ± 4.4 (0.38)

0.2 ± 1.5 (0.03)

0.1 ± 1.4 (0.02)

− 33.1 ± 3.5 (7.61)

− 27.2 ± 4.8 (6.00)

− 11.9 ± 2.5 (2.39)

Respiratory exchange ratio (VCO2/VO2)

33.9 ± 1.7

36.9 ± 1.3

− 21.9 ± 4.0 (4.16)

50.6 ± 2.4

− 31.9 ± 4.2 (6.45)

1.9 ± 1.2 (0.29)

Difference between 0%
BWS ± 90 CL (ES)

Running economy (VO2 ml·kg−1·min−1)

16.1 km·h−1
(4.47 m·s−1)

44.6 ± 2.1

Difference between
BWS ± 90 CL (ES)b

− 12.8 ± 4.1 (2.29)

Difference between 0%
BWS ± 90 CL (ES)a

− 24.7 ± 10.5 (3.10)

− 20.2 ± 9.5 (2.46)

− 12.7 ± 6.7 (1.49)

− 12.7 ± 4.8 (2.46)

− 10.0 ± 3.9 (1.92)

− 4.7 ± 2.8 (0.87)

− 8.5 ± 9.4 (0.64)

− 6.1 ± 4.9 (0.45)

− 2.8 ± 4.2 (0.20)

− 8.7 ± 8.4 (0.61)

− 8.0 ± 8.4 (0.56)

− 1.3 ± 9.6 (0.09)

− 1.2 ± 2.2 (0.20)

− 1.3 ± 1.3 (0.21)

− 1.6 ± 0.7 (0.28)

− 35.8 ± 5.8 (7.61)

− 28.6 ± 5.5 (5.78)

− 13.9 ± 3.2 (2.57)

Difference between 0%
BWS ± 90 CL (ES)

Data are means ± SD
AU arbitrary units, BPM beats per minute, BWS body weight support, CL confidence limits, ES effect size, RPE rating of perceived exertion, VO2 oxygen consumption
a
Represents the difference as percent ± 90 CL and the effects between levels of BWS and 0% BWS (e.g., 0% BWS and 10% BWS; 0% BWS and 20% BWS; 0% BWS and 30% BWS)
b
Represents the difference as percent ± 90 CL and the effects between 10% BWS and 20% BWS or between 20% BWS and 30% BWS

45.4 ± 2.4

39.6 ± 2.7

0% BWS

14.5 km·h−1
(4.03 m·s−1)

Table 4 Physiological characteristics of male runner by velocity and different levels of body weight support

− 5.7 ± 4.1 (0.64)

− 8.5 ± 5.5 (0.98)

− 2.9 ± 4.1 (0.54)

− 5.6 ± 2.0 (1.05)

1.0 ± 12.9 (0.07)

− 6.4 ± 11.6 (0.47)

− 0.7 ± 2.2 (0.05)

− 6.8 ± 6.6 (0.47)

− 0.4 ± 2.4 (0.06)

− 0.1 ± 2.0 (0.01)

− 10.1 ± 1.6 (1.83)

− 17.0 ± 6.1 (3.21)

Difference between
BWS ± 90 CL (ES)
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13.3 ± 1.8

11.9 ± 1.6

11.0 ± 1.3

9.8 ± 1.4

0% BWS

10% BWS

20% BWS

30% BWS

Difference between 0%
BWS ± 90 CL (ES)

Difference between
BWS ± 90 CL (ES)

− 9.0 ± 2.7 (0.99)

− 39.2 ± 4.3 (5.21)

− 40.8 ± 5.0 (5.35)

− 34.0 ± 5.0 (4.24)

− 15.3 ± 4.4 (1.70)

− 1.4 ± 3.6 (0.31)

− 2.0 ± 8.0 (0.09)

− 5.6 ± 8.9 (0.59)

− 19.9 ± 10.4 (2.28)

0.4 ± 7.7 (0.06)

− 11.6 ± 5.8 (0.87)
− 19.5 ± 7.8 (1.54)

− 17.2 ± 6.4 (1.33)
− 2.9 ± 4.6 (0.21)

− 6.3 ± 7.7 (0.46)

1.5 ± 1.8 (0.20)

3.0 ± 4.3 (0.39)

− 10.3 ± 2.5 (1.11)

− 22.1 ± 2.5 (2.55)

− 9.4 ± 9.6 (0.76)

− 19.9 ± 3.8 (1.70)

142 ± 15

− 6.8 ± 7.8 (0.70)
− 3.1 ± 13.2 (0.31)

− 12.0 ± 7.5 (1.27)

− 14.7 ± 8.6 (1.58)

11.9 ± 1.6

− 7.2 ± 3.2 (0.48)
− 11.6 ± 5.3 (0.79)

− 16.8 ± 5.2 (1.18)

− 26.5 ± 6.6 (1.98)

10.6 ± 1.5

13.0 ± 1.5

− 10.4 ± 3.8 (0.70)

14.4 ± 1.9

135 ± 15

151 ± 13

− 5.5 ± 4.3 (0.57)

161 ± 14

32.7 ± 2.9

38.3 ± 8.3
34.9 ± 5.4

− 4.0 ± 14.7 (0.31)

− 7.9 ± 21.2 (0.63)

− 11.6 ± 10.6 (0.94)

38.8 ± 4.4

− 26.2 ± 5.2 (2.02)

− 17.5 ± 4.1 (1.28)

− 9.5 ± 3.1 (0.66)

RPE (6–20 AU)

− 16.6 ± 6.3 (1.92)

− 12.1 ± 4.8 (1.37)

− 6.7 ± 4.2 (0.73)

Heart rate (BPM)

− 15.7 ± 12.4 (1.30)

− 10.4 ± 14.3 (0.84)

− 2.6 ± 14.1 (0.20)

− 10.6 ± 3.9 (0.74)

− 8.9 ± 3.8 (0.62)

− 5.1 ± 9.0 (0.64)

− 5.8 ± 4.4 (0.55)

− 5.9 ± 8.6 (0.46)

− 8.0 ± 13.6 (0.63)

Respiratory frequency (breathes·min−1)

41.1 ± 6.9

45.0 ± 6.0
42.3 ± 6.9

− 9.8 ± 7.3 (1.05)

− 6.0 ± 7.3 (0.63)

− 15.2 ± 13.3 (1.69)

50.8 ± 6.0

− 3.9 ± 5.3 (0.53)
− 1.0 ± 7.4 (0.14)

Minute ventilation (L·min−1)

0.85 ± 0.04

0.81 ± 0.05
0.83 ± 0.05

0.0 ± 2.7 (0.18)

− 0.6 ± 6.6 (0.22)

− 0.6 ± 9.0 (0.40)

0.84 ± 0.06

Respiratory exchange ratio (VCO2/VO2)

28.7 ± 3.4

32.0 ± 3.9

− 21.7 ± 2.2 (2.56)

− 33.2 ± 4.2 (4.22)

48.3 ± 4.0

Running economy (VO2 ml·kg−1·min−1)

14.5 km·h−1
(4.03 m·s−1)

41.1 ± 5.0

Difference between
BWS ± 90 CL (ES)b

− 14.7 ± 3.5 (1.66)

Difference between 0%
BWS ± 90 CL (ES)a

11.4 ± 1.6

12.6 ± 1.7

13.8 ± 1.6

15.1 ± 1.7

142 ± 15

148 ± 13

156 ± 15

168 ± 14

35.8 ± 3.7

37.1 ± 3.9

38.7 ± 5.6

41.2 ± 6.4

45.0 ± 7.9

46.7 ± 6.2

52.4 ± 6.5

57.0 ± 7.0

0.85 ± 0.04

0.83 ± 0.04

0.84 ± 0.05

0.86 ± 0.06

34.8 ± 4.4

38.0 ± 4.4

48.7 ± 5.5

55.6 ± 4.8

16.1 km·h−1
(4.47 m·s−1)

− 25.1 ± 6.8 (2.19)

− 16.7 ± 4.4 (1.39)

− 9.2 ± 3.8 (0.73)

− 15.9 ± 4.8 (2.00)

− 12.2 ± 5.3 (1.49)

− 7.4 ± 5.2 (0.88)

− 12.5 ± 17.5 (1.30)

− 9.2 ± 14.7 (0.84)

− 5.8 ± 16.9 (0.20)

− 21.7 ± 11.1 (1.69)

− 18.1 ± 7.9 (1.38)

− 8.2 ± 7.3 (0.59)

− 0.7 ± 7.6 (0.09)

− 3.0 ± 6.9 (0.40)

− 1.6 ± 6.9 (0.22)

− 37.6 ± 6.4 (8.04)

− 31.8 ± 5.1 (6.45)

− 13.1 ± 4.1 (2.29)

Difference between 0%
BWS ± 90 CL (ES)

Data are means ± SD
AU arbitrary units, BPM beats per minute, BWS body weight support, CL confidence limits, ES effect size, RPE rating of perceived exertion, VO2 oxygen consumption
a
Represents the difference as percent ± 90 CL and the effects between levels of BWS and 0% BWS (e.g., 0% BWS and 10% BWS; 0% BWS and 20% BWS; 0% BWS and 30% BWS)
b
Represents the difference as percent ± 90 CL and the effects between 10% BWS and 20% BWS or between 20% BWS and 30% BWS

133 ± 16

142 ± 13

10% BWS

129 ± 18

151 ± 14

0% BWS

20% BWS

30.5 ± 4.1

30% BWS

30% BWS

35.9 ± 9.7

33.7 ± 4.7

38.0 ± 4.6

0% BWS

10% BWS

36.0 ± 5.3

30% BWS

20% BWS

42.2 ± 5.5

38.3 ± 6.8

10% BWS

44.7 ± 3.7

0% BWS

20% BWS

0.81 ± 0.04

30% BWS

0% BWS

0.82 ± 0.05

0.83 ± 0.06

30% BWS

0.82 ± 0.05

26.5 ± 2.9

20% BWS

10% BWS

29.1 ± 3.3

10% BWS

20% BWS

43.5 ± 3.6

37.2 ± 4.0

0% BWS

12.9 km·h−1
(3.58 m·s−1)

Table 5 Physiological characteristics of female runners by velocity and different levels of body weight support

− 10.1 ± 8.2 (0.66)

− 8.3 ± 3.0 (0.81)

− 4.3 ± 5.7 (0.50)

− 4.3 ± 5.1 (0.61)

− 3.7 ± 8.4 (0.46)

− 3.6 ± 8.4 (0.63)

− 4.4 ± 6.5 (0.31)

− 10.8 ± 5.3 (0.79)

2.4 ± 2.6 (0.31)

− 1.4 ± 2.2 (0.18)

− 8.5 ± 3.5 (1.59)

− 21.6 ± 3.0 (4.16)

Difference between
BWS ± 90 CL (ES)
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Table 6 Equations from linear regression analyses defining
oxygen consumption (VO2 ml·kg−1·min−1) as functions of
running speed (m·s−1) at each BWS for male and female runners
Regression equations

R2

0% BWS

VO2 (ml·kg−1·min−1) = 12.807 × speed
(m·s−1) − 10.204

0.993

10% BWS

VO2 (ml·kg−1·min−1) = 10.493 × speed
(m·s−1) − 5.8871

0.999

20% BWS

VO2 (ml·kg−1·min−1) = 10.706 × speed
(m·s−1) − 14.521

0.992

30% BWS

VO2 (ml·kg−1·min−1) = 9.2819 × speed
(m·s−1) − 11.185

0.973

0% BWS

VO2 (ml·kg−1·min−1) = 9.8994 × speed
(m·s−1) − 4.2691

0.985

10% BWS

VO2 (ml·kg−1·min−1) = 9.336 × speed
(m·s−1) − 6.6136

0.967

20% BWS

VO2 (ml·kg−1·min−1) = 7.3159 × speed
(m·s−1) − 5.2166

0.957

30% BWS

VO2 (ml·kg−1·min−1) = 6.8762 × speed
(m·s−1) − 5.6689

0.929

% body weight support
Male runners

Female runners

BWS body weight support, VO2 oxygen consumption, R2 proportion of
explained variability

In contrast to Grabowski and Kram [10] and Farley
and McMahon [41] who reported an increase in contact
time and Sainton et al. [26] who found no change in
contact time, we found significant decreases in contact
time with increased BWS across all speeds. Several other
studies also found decreases in contact time with BWS
[12, 29]. Sainton et al. [26] suggest that this is a result of
greater knee extension and ankle plantar flexion while
running on a LBPPT because the aperture (Fig. 1) provides progressively more lifting force with increased
BWS. Furthermore, as BWS is increased, a shift in
regional loading of the shoe towards the forefoot occurs
due to this lifting force that may result in reduced contact time and altered running patterns, particularly at ≥
20% BWS [42]. The study of Raffalt et al. [12] is one of
the few other studies using high-trained runners and
suggests this could simply be explained by the participant’s better ability to apply force to the treadmill belt
due to their experience with LBPPT running and training background. However, running at the same speed
with increased BWS has also been shown to decrease
the vertical ground reaction force impulse [13, 15] which
can be achieved either by lower peak vertical ground
reaction forces or by shorter contact times.
The conflicting findings in biomechanical responses, particularly contact time, between studies may depend on a
number of factors, including the magnitude of unloading
(e.g., 20% BWS may produce different results than 60%
BWS), accuracy of unloading, running speed, fitness levels of

subjects, treadmill running experience, and more specifically,
LBPPT running experience [1, 32]. According to a recent
systematic review, the current LBPPT literature suggests that
there are non-linear changes in muscle activity with different
increments of BWS [1]. Some data indicate certain muscles
are not affected until significant increases in BWS occur
(e.g., significant differences present at 40% BWS but not 20%
BWS) [26]. However, other data suggest some muscles
experience changes with minimal BWS (i.e., 10% BWS) but
not with further unweighting (i.e., 30% BWS), while some
muscle experience consistent changes with incremental increases in BWS [39, 43]. Additionally, there is evidence of an
accommodation effect, such that previous research has
shown multiple trials of unweighted running are necessary
for reliable measures of metabolic cost to be made [21], and
this may be the case with biomechanical characteristics too.
The biomechanical changes in the present study with
LBPPT running contribute to less metabolic cost and
corresponding physiological changes. Specifically, if less
force needs to be produced to support body weight,
neuromuscular activation is reduced, and therefore,
there is a decreased need for energy production [1, 2].
Accordingly, it is not surprising that, as BWS increased
within a given running velocity, running economy was
improved (metabolic demand is decreased), and thus,
HR, respiratory frequency, and minute ventilation were
also reduced. Our results support a growing body of literature that metabolic cost is reduced with BWS [9, 10,
12, 18, 20–23, 26]. In the present study, we saw very
large to extremely large reductions in VO2 from 0 to
10% BWS and from 10 to 20% BWS; however, the effect,
while still moderate to large in magnitude, was attenuated with additional BWS between 20 and 30% BWS.
Kline et al. [20] reported that a proportion of metabolic
demand to BWS was nearly equivalent between 10 and
30% BWS; however, with additional BWS, the proportion of metabolic demand differed significantly from the
proportion of BWS. Here, the proportional reduction in
metabolic cost was greater than that of BWS, particularly
between 10 and 20% BWS and between 20 and 30% BWS.
Fortunately, previous research has shown that equivalent
maximal and submaximal VO2 can be achieved while
running on LBPPT by increasing the running speed to offset the reduction in oxygen consumption associated with
running with BWS [12, 20, 22, 25].
It is important to note that the metabolic demands of
running at 0% BWS on a LBPPT are lower than those of
running on a regular treadmill [32]. McNeill et al. [9]
showed that standing weight on a LBPPT was on average
7% lower than predicted body weight which according to
Kline et al. [20] resulted in a 3–9% lower metabolic cost at
running velocities between 8.0 and 17.7 km·h−1 [32]. The
reductions in weight and metabolic demand have been
attributed to the inflation of the chamber, which provides
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additional vertical and horizontal support in the mediolateral direction and reduces the need to propel in the
anterior-posterior direction [1, 32, 44]. Thus, in the
present study, the proportional decreases in metabolic demand are likely greater than that presented when compared to regular treadmill running. Similar to previous
research reporting increased variability in metabolic demand with increased BWS [9], we also found increased
variability (from 0.999 down to 0.929) from 0 and 30%
BWS; however, our coefficients of determinations (R2)
were substantially higher than those of previous studies [9,
23, 24]. The differences could be attributed to differences
in methodology between studies. Multiple studies have
implemented multiple day testing protocols to assess the
effects of LBPPT running [9, 10, 12, 20, 21, 23] which may
be warranted during long duration or maximal running
protocols where the slow drift of VO2 may be present.
However, Barnes and Kilding [2] reported that the intraindividual variation (typical error) in metabolic cost is attributable to a number of factors and is between 1.3 and 5%
at speeds between 12 and 18 km·h−1 in well-trained and
elite caliber athletes. Thus, we utilized a randomized
single-session approach, thus reducing the day-to-day
variability possibly seen in other studies. Additionally, our
subjects were highly trained distance runners who were
used to running 12–20 km during a typical training session; thus, the demand to run 36 min on a LBPPT is relatively negligible to their typical training regimen. This is
supported by the fact that RER values did not exceed 1.0 and
blood lactate samples at the conclusion of each 9-min interval series were < 4 mmol·L−1 (range 1.9 to 3.4 mmol·L−1 at
the fastest running velocity). Only one other study has
reported changes in RER during submaximal LBPPT running [9]. Our results agree with McNeill et al. [9] in that
there were no significant effects on RER with BWS at
slower running velocities; however, at faster speeds, a significant reduction occurred in both men and women. It
should be noted, however, that the 3-min intervals used in
this study represent a relatively short time period to reach
a physiological steady state and, in a lesser-trained population, would not be appropriate for analysis. However, our
data indicated there was no difference between the first
15 s and the last 15 s of the last minute analyzed, indicating our subjects did achieve a steady state.
In addition to the reduction in oxygen consumption,
we also found a significant decrease in HR and RPE during unweighted running. Studies are in agreement that
there are concomitant decreases in HR and VO2 during
BWS running [9, 12, 18, 22, 23, 26, 28, 45]. Changes in
HR tended to be similar across running speeds; however,
the magnitude of effects was attenuated with increases
in BWS. Gojanovic et al. [22] suggest that the decrease
in HR might be linked to a positive effect of lower-body
positive pressure on venous return, which, in turn, might
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be compensated adequately by an increase in stroke
volume. However, we observed that HR was similar at that
same VO2 independent of BWS, indicating that LBPP on
its own did not affect blood flow, stroke volume, and subsequently, HR. In contrast to several studies that reported
no significant change in RPE with BWS [23, 26, 45], the
reduction in RPE in our study agrees with McNeill et al.
[9] and Ruckstuhl et al. [18] who also reported significant
reductions in perception of effort at fixed running speeds
with increasing BWS. The findings of this study and other
studies suggest that BWS does not alter the relationship
between HR and VO2 or RPE and VO2, which indicates
that using HR or RPE to prescribe training intensities does
not require adjustment when running on a LBPPT with
BWS [9, 18, 23].
In addition to examining changes in physiological characteristics across levels of BWS, we found that when compared
at the same VO2 across various BWS, minute ventilation,
respiratory frequency, HR, and RPE were similar. Hoffman
and Donaghe [23] also showed that HR and RPE remained
the same for a given VO2 (25 ml·kg−1·min−1) across various
BWS in healthy untrained subjects. Because the speed necessary to achieve a given VO2 must be increased with BWS
[12, 20, 22, 25], the unaltered relationship between RPE and
VO2 suggests that the stimulus for perceived effort is related
more to aerobic demand than actual running speed [23].
The other physiological responses (HR, ventilation, respiratory frequency) are consistent with other studies describing
physiologic correlates with steady-state oxygen consumption
at specific running velocities [2, 3].

Conclusions
In conclusion, our results indicate the male and female
distance runners have similar physiological and biomechanical responses to LBPPT running. When considering
the overall effects of BWS on stride parameters, its major
influence was the large increase in flight time, which contrasted the smaller decrease in contact time resulting in
overall longer stride length and reduction in stride rate.
There was a disproportionate decrease in oxygen consumption relative to BWS which led to an attenuation of
all other physiological characteristics measured to varying
magnitudes between each level of BWS and running
speed. The rationale for the disproportional decrease in
VO2 has not been fully elucidated but may be related to
biomechanical changes leading to reduced neuromuscular
activation at a given running velocity and, therefore, a
decreased need for energy production resulting in less
metabolic cost and corresponding physiological changes.
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